DISCLAIMER: Information provided includes AI-assisted content with human review. Not financial advice. All investment decisions should be made after consulting qualified financial professionals.

POWERED BY GEMINI 3.1 PRO

Institutional-Grade
Biotech Intelligence

Decode biotech investing with sovereign AI and real-time community consensus. Deep-dive reports, FDA & clinical catalyst tracking, sentiment scoring — built for retail, priced for retail.

Start free — no card See a sample report
2,500+ words per report
Live search citations
Cancel anytime
Sentiment Evolution
User vs AI delta · last 30 days
AI Sentiment Price (norm.) +3.0 Δ
High Momentum Movers
CRSP+4.2%Phase 3 readout positive• NTLA−2.1%FDA hold lifted but cautious• AURA+0.8%Evercore fireside chat today• BEAM+6.4%CAR-T cohort beats endpoint• SANA−3.8%Insider sells filed• CRSP+4.2%Phase 3 readout positive• NTLA−2.1%FDA hold lifted but cautious• AURA+0.8%Evercore fireside chat today• BEAM+6.4%CAR-T cohort beats endpoint• SANA−3.8%Insider sells filed•
Hot Topic · CRSP
228
Reports published
351
Tickers monitored
94%
Average analyst accuracy
$100K
Simulated portfolio capital
The Hybrid Engine

AI does the digging.
You place the trade.

Our sovereign reasoning stack pairs Gemini 3.1 Pro with Google Search Grounding for verified, real-time analysis — and we're rolling in Claude Opus 4.7 to power upcoming agentic features: autonomous catalyst monitoring, multi-step thesis validation, and conversational research.

Institutional-Grade Feeds
via Claude Connectors
Bigdata.com
Real-time event analytics
Daloopa
Audited fundamentals
Box · SharePoint
Analyst research libraries
Public Data Sources
continuous crawl
SEC EDGAR
10-K · 10-Q · 8-K · Form 144
PubMed · Nature
Peer-reviewed journal papers
FDA · EMA · MHRA
Regulator approvals & alerts
ClinicalTrials.gov
Pipeline & readout calendar
Reasoning Layer
sovereign AI · cross-model
Gemini 3.1 Pro
Active
Primary reasoning core. Search Grounding for live citations on every claim.
Claude Opus 4.7
Coming Soon
Agentic features: catalyst alerts, multi-step thesis validation, conversational research.
Deep Dive Report
Thesis · Risks · Catalysts · Sentiment Score · Live citations
Real-time intelligence

We track the pulse of the market every single second.

Sentiment Engine

Bots score every headline 0–10 across Regulatory, Financial, and Scientific dimensions — then track the divergence vs price.

News Crawler

Integrated with Google News and Gemini. We filter noise to deliver only the high-impact Movers: FDA approvals, M&A, trial readouts.

Live Timeline

Automated event extraction parses years of history into a clean chronological timeline for every company — updated continuously.

Live activity

What our analysts are watching right now.

Updated every minute
FDA Approvals 8.4 STRONG BUY

FDA grants accelerated approval to CRSP-001 for sickle cell

Bloomberg · 2h ago

+12.4%
124 12
Clinical Trials 6.1 BUY

Aura Biosciences pivotal CoMpass trial enrols 312th patient

PR Newswire · 4h ago

+0.8%
124 12
M&A & Deals 7.2 BUY

Lilly buys oncology pipeline from Verve in $2.8B all-cash deal

Reuters · 6h ago

+5.3%
124 12
Biotech Stocks 8.0 STRONG BUY

Beam Therapeutics CAR-T cohort beats primary endpoint

Endpts · 8h ago

+6.4%
124 12
How it works

From ticker to thesis in four steps.

01
Pick a ticker

Search 350+ biotech companies across US and EU.

02
AI generates the report

Gemini 3.1 Pro + Search Grounding writes a deep-dive thesis in under 4 minutes.

03
Community pressure-tests it

Bull vs Bear debate, sentiment voting, accuracy tracking.

04
Alerts on every catalyst

FDA letters, trial readouts, insider sells — straight to your inbox.

Crowdsourced Alpha

AI provides the data.
Our community provides the wisdom.

Join Thesis Wars to debate the Bull vs Bear case, earn Analyst Accuracy badges, and steer the consensus score on every ticker.

Join the discussion
Bull Case

Community-validated upside thesis with cited evidence.

Bear Case

Critical risk analysis — the trade you should reconsider.

Analyst Accuracy
94%

Top 5% of all analysts this quarter

Ready to outperform?

Join thousands of biotech investors using sovereign AI to find their next winning trade.

Sign Up Free See pricing

No card · Cancel anytime · Free during beta

Early access

Be first in line

Drop your email and we'll send you an invite when subscriptions open. Free tier. No card. Unsubscribe anytime.